Professional Documents
Culture Documents
Acute Heart Failure COMET 2024
Acute Heart Failure COMET 2024
Acute Heart Failure COMET 2024
4
Hollenberg et al.JACC VOL. 74, NO. 15, 2019
Hollenberg et al.JACC VOL. 74, NO. 15, 2019 5
Hollenberg et al.JACC VOL. 74, NO. 15, 2019 6
Diagnosis and Treatment of
Acute Heart Failure
Definition AHF
Diagnosis of AHF
Treatment of AHF
Definition of AHF
Acute Heart Failure rapid onset or worsening of symptoms and/or signs of HF a
life-threatening medical condition requiring urgent evaluation and treatment
Definition AHF
Diagnosis of AHF
Treatment of AHF
Main Patho-Mechanisms Leading to AHF
Definition AHF
Diagnosis of AHF
Treatment of AHF
AHF Diagnosis
• Initial diagnosis of AHF: should be based on
• a thorough history assessing symptoms
• prior cardiovascular history
• potential cardiac and non-cardiac precipitants
ECG
CXR
Lab: Biomarkers
Echocardiography
Haemodynamic
instability
Immediate
echocardiography
Acute life-threatening
structural or functional
cardiac abnormalities
Definition AHF
Diagnosis of AHF
Treatment of AHF
• The vast majority of acute heart failure episodes are characterized by increasing symptoms and signs of congestion with
volume overload
• The goal of therapy in those patients is the relief of congestion through achieving a state of euvolaemia, mainly through the
use of diuretic therapy
• The appropriate use of diuretics however remains challenging, especially when worsening renal function, diuretic resistance
and electrolyte disturbances occur
• When patients with heart failure with reduced (HFrEF) or preserved ejection fraction (HFpEF) decompensate, they often
can present with a similar profile of congestion
The goals of therapy in patients presenting with congestion and volume overload consists of
(i) Achieving thorough decongestion without residual volume overload (the optimal stopping
point of decongestive therapy is often dif cult to determine)
(ii) Ensuring adequate perfusion pressures to guarantee organ perfusion
(iii) Maintaining guideline-directed medical therapies as these medications may also increase
diuretic response and improve long-term survival
26
fi
27
Mullens, European Journal of Heart Failure (2019)
28
Hollenberg et al.JACC VOL. 74, NO. 15, 2019
AHF Management
30
Parenteral Vasodilation Therapy in Patients Hospitalized With HF
• Withholding or reducing beta-blocker therapy should be considered in patients with marked volume overload or marginal
low cardiac output
• True contraindications are rare, such as advanced degree atrioventricular block for beta blockers in the absence of
pacemakers; cardiogenic shock that may preclude use of certain medications until resolution of shock state; or angioedema
for ACEi or ARNi
Paul A. HeidenreichCirculation,Volume 145, Issue 18, 3 May 2022 33
34
Hollenberg et al.JACC VOL. 74, NO. 15, 2019
Pathway Optimization HF Treatment
35
2017ACC Expert consensus decision pathway to OMT. J Am Coll Cardiol.2017;23:1-26.
MODERN CONCEPT IN HF MANAGEMENT
CONTINUE & COMPREHENSIVE TREATMENT
APPROACH
36
Mesquita AT et al.Int J Cardiovasc Sci. 2017;30(1):81-90
Take Home Messages
• AHF the most common cause of hospital admission
• The main contributor to the huge health care costs of heart failure
• An initial step in the diagnostic workup of AHF is to rule out alternative
causes for the patient’s symptoms and signs
• In paralel evaluation circulatory and respiratory status, coexisting life-
threatening clinical conditions and/or precipitants that require urgent
treatment/correction
QUESTION
38
AHF Diagnosis
• Physical exam should assess:
signs/symptoms of congestion
• Orthopnea
• >> JVP
• Edema
• Ascites
Signs/symptoms
• Rales of hypoperfusion
•
• Narrow pulse
Abd-Jugular pressure
reflux
• Cold extrimities
• Agitation, << consciousness
• Worsening renal function Ponikowski P, et al. Eur Heart J (2016) , 43-55
In-Hospital Mortality, According to Precipitating
Factors in the OPTIMIZE-HF Registry